STEMI - ST Elevation Myocardial Infarction
75
9
12
25
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.0%
6 terminated out of 75 trials
80.6%
-5.9% vs benchmark
24%
18 trials in Phase 3/4
12%
3 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (75)
SuperSaturated Oxygen Comprehensive Observational Registry
Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
Emergency Medical Services (EMS) Telehealth to Speed STEMI Reperfusion
Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction
Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock
Hong Kong Cardiogenic Shock Initiative
Epicardial Cardiac Fat-CT (EPIC-CT)
Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI
Multicenter Cohort of STEMI Patients
A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI
Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
National Cardiogenic Shock Initiative
Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction
AccuIMR Predicts Microvascular Obstruction and Infarct Size in STEMI Patients
The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment
TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk